how to switch Rezulin patients to one of the newer glitazones

April 2000

Now that Rezulin is going off the market, physicians are asking how to switch Rezulin patients to one of the newer glitazones.

Many diabetic patients benefited from Rezulin...but the newer glitazones, Actos and Avandia, are less likely to cause serious liver toxicity.

To switch patients over, wait one week after stopping Rezulin and get a baseline liver function test.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

alarming increase in type 2 diabetes in children and teens
Dermatology new prescription "nail polish" called Penlac
Supplements news that vitamin C might increase the risk of heart disease
Supplements huperzine A to improve memory and treat Alzheimer's
Diabetes how to switch Rezulin patients to one of the newer glitazones
Diabetes new devices will allow patients to test blood sugar from their arm, abdomen, or thigh
Diabetes pharmacists to get involved in diabetic foot screening
Women's Health doxylamine and pyridoxine combo is safe and effective for treating nausea and vomiting during pregnancy
SSRIs can cause patients to clench and grind their teeth
low doses of gabapentin (Neurontin) for muscle cramps
Cardiology which drugs to use to prevent stroke
Cardiology patients don't need to stop low-dose aspirin before ORAL surgery
Substance Use Disorder dextromethorphan abuse
Infectious Diseases Biaxin XL and regular Biaxin (clarithromycin) tablets
Infectious Diseases Prevnar, the first pneumococcal vaccine that can be given to children under 2
Hypertension now urging physicians to avoid treating hypertension with alpha blockers
Practice Propulsid (cisapride) will go off the market July 14, 2000